Introduction
Gestational diabetes mellitus (GDM) is defined as "glucose intolerance of any degree with onset or first recognition during pregnancy". It affects 3 -14 % of pregnant women and its prevalence has doubled in the last 8 years, a 12% increase per year 1 
.
It has long been deduced that pregnancy outcomes from GDM, reported frequently in the literature obtained from studies in the developed western world, would not be applicable unerringly to countries in the eastern hemisphere, with its different cultural, social and economic background. This study was conducted on 200 antenatal mothers diagnosed with GDM, from 2007 to 2009, at the Teaching Hospital, Kandy, Sri Lanka, to determine the outcomes of these pregnancies.
Objective
The objective of this study on 200 antenatal mothers with GDM, is to ascertain the complications and clinical outcomes of these pregnancies and compare these with results obtained from the western literature.
Materials and Methods
This study was conducted at the antenatal clinic and wards of the Teaching Hospital, Kandy, which has one of the busiest maternity wards in Sri Lanka, with over 6000 annual deliveries per unit. A detailed history was obtained from each expectant mother attending the antenatal clinic.
Mothers with the following risk factors, eg. maternal age more than 35 years, previous infant weighing more than 3500 g, glycosuria in second urine sample, previous unexplained fetal demise, previous pregnancy with GDM, strong immediate family history of Type 2 Diabetes Mellitus (T2DM ) or GDM, obesity (>90 kg), fasting glucose value greater than 140 mg/dl (7.8 mmol/L) or random glucose value greater than 200 mg/dl (11.1 mmol/L), were selectively screened for GDM.
This selective screening involved a 75 g standard Oral Glucose Tolerance Test ( OGTT ) performed in a laboratory with reputed quality control measures. The OGTT was performed in the morning after an overnight fast of between 8 and 14 hours. During the three previous days the subject was on an unrestricted diet and unlimited physical activity. The subject was seated during the test and was given a standard solution containing 75 g of glucose to drink within a 5 minute time frame.
GDM was diagnosed using the 2006 WHO Diabetes criteria of venous blood and plasma glucose levels, as depicted in Table 1 2 .
with trouble-free self-administration even amongst the poorly educated. On an average 2/3 of the total daily dose was given in the morning and 1/3 in the evening. Regular check-up was by the fasting and 2-hour post lunch, plasma sugar estimations. The use of glucometers were discouraged.
The criteria used for targeted levels of glycemic control were according to recommendations of the Fifth International Workshop Conference on Gestational Diabetes A detailed assessment of the fetal morphology was offered to all, whenever feasible at 18 to 20 weeks.
(d) Delivery
Due to the liberal protocol of the unit for caesarean section for delivery of insulin-dependant diabetics, 78% of them were delivered surgically, most after 38 completed weeks of gestation. The rest with a good Bishops score were induced between 38 to 39 weeks and delivered vaginally under enhanced supervision (e) Post-natal advice
The mothers were counselled on a combination of breastfeeding, lifestyle changes with increased physical activity, weight loss and a healthy diet, which could significantly reduce the maternal risk for T2DM .
(f) Post-partum follow up
A glucose tolerance test was performed 6 weeks post-partum to determine whether it was GDM or a new diagnosis of Type 2 Diabetes.
(g) Long term follow up
Mothers who had delivered earlier in the series were followed, where feasible, for a period of two years with OGTT.
Results
A section of the trial of patients requiring insulin for optimal blood glucose control, with the OGTT results and insulin dosages are tabulated in Table 2 .
The control of the glycaemic levels were obtained with dietary regulation and insulin therapy.
(a) Dietary regulation
The foundation of treatment for all patients was diet adherence with the percentage of carbohydrates lower than 40%. Mothers with a fasting plasma glucose < 105 mg/dl were selected for a 'trial of diet therapy', without medication, for a 2-to 4-week period 3 . Failure of dietary regulation for blood glucose control beyond this period required insulin therapy for optimal control. Mothers with a fasting glucose concentrations more than 115 mg/100 mL, were commenced instantaneously on insulin therapy in addition to dietary regulation. 
Managing gestational diabetes -a two year study of 200 patients
The clinically significant results obtained from this study is listed below:
(1) Risk factors for GDM 65% of the mothers documented diabetes in an immediate family member. Obesity, the next most common risk factor stipulated in the literature was found in only 5% of mothers with a weight of over 90 Kg.
(2) Public Awareness of the major risk factor
The percentage of mothers who had carried out at least one blood-sugar estimation prior to conception was 34 %. Only 31% of the antenatal mothers, with a family history of T2DM, the principal risk-factor, had checked their blood sugar profile prior to conception. 28% of the mothers in the present series gave a previous history of GDM which has been alleviated post partum. It is also noted that only 50% of them had checked their blood sugar profile prior to this conception.
(4) Birth weight
The average birth weight of babies in this study was 3206 grams and 30% of them had a birth weight higher than 3500 grams.
(5) Congenital anomalies
A congenital abnormality rate of 2.5% is reported, with cardiac anomalies and an imperforate anus. One baby died 30 days later due to multiple fatal anomalies.
(6) Still births
There were three still births in the series. Two were unexplained and the other due to undetected reversal of the umbilical blood flow.
(7) PBU care 34% of the babies needed to be admitted to the Special Care Baby Unit (SCBU) for observation and sometimes for respiratory difficulty. Excluding the extremes, the average SCBU stay was 2 to 3 days.
(8) Maternal weight-gain during pregnancy
The maternal weight gain during this pregnancy Table 2 Kalinga Nanayakkara was in par with the non-diabetic population with 5% of mothers gaining more than 20 Kg and 10% gaining more than 15 Kg.
(9) Post-partum follow up 22% of women were found to have a new diagnosis of type 2 diabetes mellitus, postpartum. They were referred to the physician for follow up therapy.
(10) Medication during breast-feeding
All of the 22% of mothers who were found to have a new diagnosis of type 2 diabetes mellitus, postpartum, was either still on insulin or oral antidiabetic agents while breast feeding.
(11) Long term follow-up
Long-term follow-up showed that 8% of mothers who were normotolerant or with impaired glucose tolerance post-partum were found to be diabetic just 2 years after delivery. Two case reports are documented below:
(12) Post partum diabetes with high pregnancy GTT levels
It was observed that 77% of mothers who developed T2DM later had very high blood sugar profiles in their antenatal GTTs with fasting levels over 150 mg%, one-hour and twohour levels over 350 mg%. They were established type 2 diabetics, diagnosed for the first time during this pregnancy.
(13) Fallacy of diligent dietary control
Although nearly all mothers in this study reported diligent adherence to dietary advice, intensely questioned six months later, only 58% vouched for the advised dietary restrain.
(14) Childhood obesity
During the short follow-up period in this study, 86% of the mothers reported a normal weight gain for their children and 14% less than normal.
Discussion
Diabetes, which is spreading rapidly around the globe in a 'pandemic', has a varying incidence, affecting 8.6% of Europeans to 14% for the Hispanics. The prevalence in Sri Lanka stands at 11.5% 5 . A glaring deficiency in pre-pregnancy counselling is noted with the detail that only 34% of mothers in this study had taken at least one blood-sugar estimation prior to conception. The finding of 65% of the mothers documenting diabetes in an immediate family member is significant and we authenticate it as the major risk factor for GDM in this series. This is in concurrence with other series of published data 6, 7, 8 . However, it was noted that the public awareness of this disability is inadequate, with only 31% of them checking their blood sugar profile prior to this conception.
Obesity, the next frequent risk factor stipulated in the literature 8 , was found only in 5% of mothers who weighed over 90 Kg. Literature survey shows that the risk in the second pregnancy for GDM was 41.3% among women with previous GDM vs. 4 .2% in women without previous GDM (OR, 13.2; 95% confidence interval [CI], 12.0 -14.6) 9 . Although 28% of the mothers in the present series gave a previous history of GDM, it is disappointedly noted that only 50% of them had checked their blood sugar profiles prior to this conception.
A significant majority of 88% of mothers in the present study needed insulin therapy for optimal blood sugar control as against a figure between 30-50% quoted in the western literature 3 . Dietary control is 'better said than done' in the South Asian perspective where social conviction demands 'eating for two ' in addition to dietary regulation. However, as there is a threefold higher rate of large for gestational age infants in diet-treated patients when the fasting plasma glucose >95 mg/dl, some consider it reasonable and appropriate to recommend assigning these patients to additional pharmacological therapy 11 .
Although evidence suggest that glibenclamide and metformin may be a reasonable alternative to insulin for some women with gestational diabetes, especially those who have fasting glucose concentrations less than 110 mg/100 mL 12, 13 , it was not used in the present series. The cost to the health services of the country is epitomized by the reality that one-third of the babies needed SCBU care even for two to three days. The three still births in the series conveys the need for closer supervision in these complicated pregnancies, with umbilical artery blood flow estimations, after 34 weeks of gestation. A significant congenital abnormality rate of 2.5 % is reported, with cardiac anomalies and an imperforate anus. This is in accordance with population-based registry and database studies showing anomalies for gestational diabetes only 1.2 times higher than in the general population (95% CI 1.1-1.3) as against being 2-to 3-fold higher for established diabetics 14 . Also adjusted analyses show a 3.4-fold increase in anomalies for women with gestational diabetes with fasting hyperglycemia (P<0.001), and no difference in risk for women with gestational diabetes with normal fasting glucose when compared with women without diabetes 15 suggesting undetected type 2 diabetes. This is amply amplified in the present series with 22% of mothers found to have a new diagnosis of type 2 diabetes mellitus, post-partum. The average birth weight of babies in this study was 3206 grams which is higher that the average birth weight for Sri Lankan babies of 2854 grams 16 and 30% of them had a birth weight higher than 3500 grams.
It was inspiring to note that of the post-natal advice given to these mothers which could significantly reduce the maternal risk for T2DM , breast-feeding was diligently observed. However, the same could not be observed in lifestyle changes such as increased physical activity and weight loss, which has been documented to reduce the development of type 2 diabetes by 58 percent during a 3-year period 17 . The short follow-up period of this study was inadequate to substantiate the documented relationship between intrauterine exposure to maternal hyperglycaemia with the risk of childhood obesity 18, 19 and features of the metabolic syndrome, such as hypertension, dyslipidaemia and microalbuminuria 20 . 86% of the mothers reported a normal weight gain for their children and 14% less than normal. Women with pGDM have at least a 7.5-times increased risk of developing T2DM in the future compared with those with normoglycemic pregnancy with a 35 to 60 percent chance of developing diabetes in the next 10-20 years 21 . The recommendations protocol of the American Diabetes Association for annual or regular OGTT of women with pGDM 22 who are normotolerant for the 6-week post-partum OGTT is thoughtful, when considering the 8% of mothers who were normotolerant or with impaired glucose tolerance post-partum and found to be diabetic just 2 years after delivery. Bellamy and colleagues in 2009 reported that the relative risk of 4.69 of developing T2DM within 5 years of a pregnancy complicated by gestational diabetes, doubled to 9.34 when examined more than 5 years postpartum 23 . However, the use of oral antidiabetic agents for these normotolerant women for T2DM prevention, known to reduce the risk by 31 percent 21 , was not offered in the present study.
Conclusion and recommendations
It is noted that adequate prominence has not been given on the need to check the blood-sugar profile prior to pregnancy. Many studies have emphasized that pre-conception counseling with advice to keep the pre-conception glycosylated hemoglobin (HbA1c) at or below 7% has lead to a decrease in the risk of congenital malformations 24 . More publicity by the health professionals and in the print and electronic media must be made to create public awareness on the importance of a family history of diabetes being the major risk factor for GDM. As it was observed that 77% of mothers who developed T2DM later had very high blood sugar profiles in their antenatal GTTs it is recommended that the obstetricians themselves must be guided to keep contact details of them along with details of mothers requiring higher doses of insulin for optimal blood sugar control, for subsequent periodical recall and testing.
The emphasis must also be for the need for closer supervision of these complicated pregnancies, with umbilical artery blood flow estimations, after 34 weeks of gestation. The frightening statistic of one-fifth of the mothers assembling a new diagnosis of type 2 diabetes mellitus, in the immediate post-partum assessment gives an indication to the perilous spread of diabetes in this country. Insulin therapy involves daily injections, which may lead to suboptimal adherence by many women in poorer countries due to its unavailability, storage difficulties and its cost. Although oral antidiabetic agents endorsed by the Fifth International Workshop on Gestational Diabetes and the North American Diabetes in Pregnancy Study Group 25 for GDM were not used in the present series, it is self-evident that given the choice of insulin injection versus tablets, patients will invariably prefer taking tablets, instead of two to three daily injections.
